GlassScriptPhysician profile
Pamela K Snook
NPI 1205903853
$14,513.71
in general payments reported to CMS, 2019-2025
15 companies · $9,886 in 2025
The $9,886 reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $17.53 · 2021: $72.12 · 2022: $337 · 2023: $357 · 2024: $3,621 · 2025: $9,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,200.00 |
| Food and Beverage | $664.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $13,200.00 | 2024-2025 | Bovine Collagen |
| Hologic Sales and Service, LLC | $272.93 | 2020-2023 | Novasure, Coolseal Generator |
| Abbvie INC. | $257.27 | 2019-2024 | Liletta |
| Organon LLC | $144.50 | 2022 | |
| Gynesonics, INC. | $125.33 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $99.79 | 2022-2025 | Sos |
| Pfizer INC. | $98.58 | 2022-2024 | |
| Smith+Nephew, INC. | $97.69 | 2019 | |
| Astellas Pharma US INC | $44.22 | 2023 | Myrbetriq, Veozah |
| Millicent US INC | $41.31 | 2022 | |
| Merck Sharp & Dohme LLC | $35.05 | 2022-2023 | Gardasil 9 |
| Meditrina | $32.35 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.49 | 2023 | |
| Minerva Surgical, INC | $23.28 | 2021 | |
| Medline Industries LP | $13.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Snook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.